⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
CLDI News
Calidi Biotherapeutics, Inc.
Calidi Biotherapeutics Presented New CLD-401 Data and In Situ TCE Platform Advances at the ESMO Congress 2026, Including Highlighting the Potential of its RedTail Gene Medicine Platform to Turn Tumors into Localized TCE Biofactories
globenewswire.com
CLDI
Calidi Biotherapeutics to Present New CLD-401 Data and In Situ TCE Platform Advances at the ESMO Congress 2026
globenewswire.com
CLDI
Form 8-K
sec.gov
CLDWW
CLDI
Calidi Biotherapeutics Received NYSE American Notification Letter Regarding Stockholders’ Equity Deficiency
globenewswire.com
CLDI
Form 8-K
sec.gov
CLDWW
CLDI
Calidi Biotherapeutics Announces $1.2 Million Registered Direct Offering
globenewswire.com
CLDI
Calidi Biotherapeutics to Participate in the H.C. Wainwright 28th Annual Global Investment Conference
globenewswire.com
CLDI
Cleveland Diagnostics Appoints Valerie Dixon as Chief Financial Officer
businesswire.com
CLDI
Form 8-K
sec.gov
CLDWW
CLDI
Calidi Biotherapeutics Reports Second Quarter 2026 Financial Results and Recent Business Highlights
globenewswire.com
CLDI